corbus pharmaceuticals holdings, inc. (nasdaq: crbp) is a clinical stage drug development company targeting rare, chronic, and serious inflammatory and fibrotic diseases with clear unmet needs.   the company's lead product candidate, resunab™, is a first-i

Corbus Pharmaceuticals Holdings, Inc.

Sold short CRBP

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

test user

Sold all CRBP

Sold 20% of CRBP

New position in CRBP

Miguel Gómez Bravo

Smith

James Irvine

Sold 13% of CRBP

Xiao

Bought 5% more CRBP

Peter Munyambu

Bought 6% more CRBP

Bought 12% more CRBP

Bought 7% more CRBP

Bought 8% more CRBP